Mesa, Arizona, March 28, 2022 – Fusion Orthopedics, LLC (“Fusion”) (www.fusionorthopedics.com) is a medical device company established in 2014 and known for numerous innovative technologies in the foot and ankle orthopedic market. The disruptive nature of Fusion’s patent pending LapilockTM 4D Advanced Bunion SurgeryTM has caught the attention of Treace Medical Concepts, Inc. (“Treace”) due to the potential disruption of Treace’s Lapiplasty® market share. Fusion’s position is that the LapilockTM 4D Advanced Bunion SurgeryTM is different than and superior to the Lapiplasty® 3D Bunion CorrectionTM, insofar as Fusion has a plurality of pending patent applications covering the LapilockTM 4D Advanced Bunion SurgeryTM.
Notable reasons for Fusion doubling down on its LapilockTM 4D Advanced Bunion SurgeryTM include:
- Direct consumer education to generate leads at lapilockbunionsurgery.com;
- Flexibility in pricing to address unmet market demand;
- Surgeon’s choice of over 13 options for fixation;
- Counter pressure will never break a patient’s second metatarsal;
- Minimal bone resection to better maintain first metatarsal length;
- Adjustability of dorsal flex or plantar flex of the first metatarsal;
- Fulcrum-less surgical technique; and
- Single jig for all steps to eliminate risk/loss of correction.
Fusion aims to stand out by being a rep-centric, comprehensive foot and ankle solution. In the medical device industry, it is common practice to leave reps “high-and-dry,” especially with reduction of commissions and reduction of territory or compulsory W-2 status. Fusion takes great pride in providing sales representatives a trustworthy partner.
It is Fusion’s practice to recognize and respect the intellectual property of others. Fusion is committed to being an innovator in technology related to foot and ankle orthopedic devices and stands by its disruptive technology, especially when wrongfully accused of patent infringement, copyright infringement, trademark infringement, and unfair competition. Fusion fiercely disputes the baseless claims set forth by Treace, as filed in the U.S. District Court of Arizona.
About Fusion Orthopedics
Fusion was founded in 2014 on the notion to make “Everything Better.” Fusion’s focus is to produce innovative medical devices that address the under-served needs of the foot and ankle surgical community. Fusion aims to leave its footprint in a multi-billion-dollar U.S. market by specializing in anatomically precise designs based on feedback received directly from industry professionals. Fusion bridges the gap between physicians and engineers, allowing for the conception of implant systems that match the market’s ever-changing needs. Fusion’s relational-based design process allows for the development of products that aim to improve patient surgical outcomes and decrease time in the operating room, while maintaining cost competitiveness. Like many industries the orthopedic implant industry is highly competitive.